VCEL Stock Price and Chart NASDAQ:VCEL TradingView India

The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure. MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication.

A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, March 28, 2023, and so far it has risen 8.31%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence .

6 employees have rated Vericel Chief Executive Officer Nick Colangelo on Glassdoor.com. Nick Colangelo has an approval rating of 49% among the company’s employees. This puts Nick Colangelo in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to invest in mild weather with cat bonds on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

Vericel downgraded to hold from buy at Truist

CEO, President & https://1investing.in/ to buy US$417k worth of stock. The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction. The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength.

TCON, NMTR, and PTCT are the stocks whose asset turnover ratios are most correlated with VCEL. VCEL scores best on the Quality dimension, with a Quality rank ahead of 73.64% of US stocks. We have 9 different ratings for every stock to help you appreciate its future potential. We’d like to share more about how we work and what drives our day-to-day business.

New 90-day high: US$51.40

Investing.com – U.S. equities were lower at the close on Monday, as losses in the Basic Materials, Industrials and Consumer Goods sectors propelled shares lower. Investing.com – U.S. equities were lower at the close on Wednesday, as losses in the Oil & Gas, Utilities and Basic Materials sectors propelled shares lower. Investing.com – U.S. equities were higher at the close on Tuesday, as gains in the Basic Materials, Industrials and Utilities sectors propelled shares higher.

Truist Financial boosted their target price on shares of Vericel from $29.00 to $31.00 and gave the stock a “hold” rating in a report on Monday, February 27th. Finally, HC Wainwright restated a “buy” rating and set a $37.00 target price on shares of Vericel in a report on Friday, January 27th. Three analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $35.50. Several other large investors have also modified their holdings of the company.

Vericel to Present at the Ladenburg Thalmann Healthcare Conference

The stock’s price range for the 52-week period managed to maintain the performance between $17.30 and $40.35. While the effectiveness of this highly sought-after metric is questionable… According to 11 analysts, the average rating for VCEL stock is “Buy.” The 12-month stock price forecast is $38.51, which is an increase of 25.30% from the latest price. Investing.com – Vericel Corp Ord reported on Wednesday third quarter erl-15477||earnings that beat analysts’ forecasts and revenue that fell short of expectations.

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world. The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank would place in the bottom 1%.

Its preapproval stage product is NexoBrid, a biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. 4 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Vericel in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock.

The company was founded on March 24, 1989 and is headquartered in Cambridge, MA. At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.52% per year. These returns cover a period from January 1, 1988 through February 6, 2023.

The average of price targets set by Wall Street analysts indicates a potential upside of 52.8% in Vericel Corporation . While the effectiveness of this highly sought-after metric is questionable,… Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Vericel Corporation shares are logging -25.45% during the 52-week period from high price, and 73.87% higher than the lowest price point for the same timeframe.

Finally, StockNews.com started coverage on shares of Vericel in a research report on Thursday, March 16th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $35.50. Several equities research analysts have commented on the stock. StockNews.com started coverage on shares of Vericel in a research report on Thursday, March 16th. Truist Financial boosted their target price on shares of Vericel from $29.00 to $31.00 and gave the stock a “hold” rating in a report on Monday, February 27th.

Vericel Corporation is engaged in advanced therapies for the sports medicine and severe burn care markets. The Company markets two cell therapy products and one specialty biologic product in the United States. MACI is an autologous cellularized scaffold product indicated for the repair of symptomatic, single ormultiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price. / Sales ,31x Nbr of Employees – Free-Float 98,8% More FinancialsCompanyVericel Corporation is engaged in advanced therapies for the sports medicine and severe burn care markets.

An industry with a larger percentage of Zacks Rank #1’s and #2’s will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4’s and #5’s. The Zacks Industry Rank assigns a rating to each of the 265 X Industries based on their average Zacks Rank. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. NA2.63BNP Paribas Asset Management USA, Inc.2.31Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. Vericel Corporation saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase…

12.47% of the outstanding shares of Vericel have been sold short. Vericel Corp.’s stock rocketed 92% in very active premarket trade Thursday, after the biotechnology company announced positive trial results for its heart failure treatment. Represents the company’s profit divided by the outstanding shares of its common stock. Independent Director exercised options to buy US$288k worth of stock.

• Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $35.50.
• According to 11 analysts, the average rating for VCEL stock is “Buy.” The 12-month stock price forecast is $38.51, which is an increase of 25.30% from the latest price.
• Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.
• Advisors Asset Management Inc. now owns 7,197 shares of the biotechnology company’s stock worth $167,000 after purchasing an additional 452 shares in the last quarter.
• Do the numbers hold clues to what lies ahead for the stock…
• Over the next eight years, experts predict that Fair Value will grow by 100.00%.

CompareVCEL’s historical performanceagainst its industry peers and the overall market. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated. Data are provided ‘as is’ for informational purposes only and are not intended for trading purposes. Data may be intentionally delayed pursuant to supplier requirements.

Shares Sold ShortThe total number of shares of a security that have been sold short and not yet repurchased.Change from LastPercentage change in short interest from the previous report to the most recent report. Exchanges report short interest twice a month.Percent of FloatTotal short positions relative to the number of shares available to trade. Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.